CLINICAL TRIAL EXPERIENCE WITH THE 9-VALENT HPV VACCINE BY RACE/ETHNICITY: A COMBINED ANALYSIS FROM SEVEN PHASE III CLINICAL STUDIES

被引：0
|
作者：
Clark, Liana R. [1 ]
Luxembourg, Alain T. [1 ]
机构：
[1] Merck & Co Inc, Rahway, NJ USA
来源：
JOURNAL OF ADOLESCENT HEALTH | 2016年 / 58卷 / 02期
关键词：
D O I：
10.1016/j.jadohealth.2015.10.246
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
225
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [31] AN INVESTIGATION OF THERAPEUTIC EFFECT OF ESLICARBAZEPINE ACETATE COMBINED WITH CARBAMAZEPINE: POOLED ANALYSIS OF THREE PLACEBO-CONTROLLED PHASE III CLINICAL STUDIES
    Soares-da-Silva, Patricio
    Versavel, M.
    Nunes, T.
    Maia, J.
    Almeida, L.
    EPILEPSIA, 2009, 50 : 122 - 123
  • [32] Phase I clinical trial of peptide vaccine derived from HSP105 and analysis of immune response in vaccinated patients
    Shimizu, Yasuhiro
    Yoshikawa, Toshiaki
    Syoda, Kayoko
    Nosaka, Kazuto
    Shimomura, Manami
    Mizuno, Shoichi
    Wada, Satoshi
    Fujimoto, Yuki
    Kohashi, Kenichi
    Kojima, Takashi
    Endo, Itaru
    Nakatsura, Tetsuya
    CANCER SCIENCE, 2018, 109 : 1334 - 1334
  • [33] Immunogenicity and safety of two novel human papillomavirus 4-and 9-valent vaccines in Chinese women aged 20-45 years: A randomized, blinded, controlled with Gardasil (type 6/11/16/18), phase III non-inferiority clinical trial
    Shu, Yajun
    Yu, Yebin
    Ji, Ying
    Zhang, Li
    Li, Yuan
    Qin, Haiyang
    Huang, Zhuhang
    Ou, Zhiqiang
    Huang, Meilian
    Shen, Qiong
    Li, Zehong
    Hu, Meng
    Li, Chunyun
    Zhang, Gaoxia
    Zhang, Jikai
    VACCINE, 2022, 40 (48) : 6947 - 6955
  • [34] Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience
    Metzger-Filho, Otto
    de Azambuja, Evandro
    Bradbury, Ian
    Saini, Kamal S.
    Bines, Jose
    Simon, Sergio D.
    Van Dooren, Veerle
    Aktan, Gursel
    Pritchard, Kathleen I.
    Wolff, Antonio C.
    Smith, Ian
    Jackisch, Christian
    Lang, Istvan
    Untch, Michael
    Boyle, Frances
    Xu, Binghe
    Baselga, Jose
    Perez, Edith A.
    Piccart-Gebhart, Martine
    ONCOLOGIST, 2013, 18 (02): : 134 - 140
  • [35] Safety of Bimekizumab in Patients with moderate to severe Psoriasis: Analysis of Pooled Data from Phase II and III Clinical Studies
    Reich, K.
    Blauvelt, A.
    Lebwohl, M.
    Papp, K. A.
    Rich, P.
    Strober, B.
    De Cuyper, D.
    Madden, C.
    Peterson, L.
    Vanvoorden, V.
    Warren, R. B.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 64 - 64
  • [36] Integrated safety analysis of abrocitinib for the treatment of moderate-to-severe atopic dermatitis from the phase II and phase III clinical trial programme
    Simpson, E. L.
    Silverberg, J. I.
    Nosbaum, A.
    Winthrop, K.
    Guttman-Yassky, E.
    Hoffmeister, K. M.
    Zhang, M.
    Farooqui, S. A.
    Johnson, S.
    Thorpe, A.
    Rojo, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E133 - E134
  • [37] Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Nosbaum, Audrey
    Winthrop, Kevin L.
    Guttman-Yassky, Emma
    Hoffmeister, Karin M.
    Egeberg, Alexander
    Valdez, Hernan
    Zhang, Min
    Farooqui, Saleem A.
    Romero, William
    Thorpe, Andrew J.
    Rojo, Ricardo
    Johnson, Susan
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (05) : 693 - 707
  • [38] Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program
    Eric L. Simpson
    Jonathan I. Silverberg
    Audrey Nosbaum
    Kevin L. Winthrop
    Emma Guttman-Yassky
    Karin M. Hoffmeister
    Alexander Egeberg
    Hernan Valdez
    Min Zhang
    Saleem A. Farooqui
    William Romero
    Andrew J. Thorpe
    Ricardo Rojo
    Susan Johnson
    American Journal of Clinical Dermatology, 2021, 22 : 693 - 707
  • [39] Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV)
    Okada, Kenji
    Miyazaki, Chiaki
    Kino, Yoichiro
    Ozaki, Takao
    Hirose, Mizuo
    Ueda, Kohji
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (02): : 275 - 283
  • [40] Baseline vaccine type seropositivity and DNA positivity of women aged 24-45 participating in a phase III clinical trial of quadrivalent HPV (type 6/11/16/18) L1 VLP vaccine
    Makhija, S.
    GYNECOLOGIC ONCOLOGY, 2008, 109 (01) : 158 - 159
12345